GLP-1 exerts anti-obesity effects by delaying gastric emptying, reducing food intake, stimulating insulin release, improving insulin sensitivity (Van Can et al., 2014), and sending appetite suppressor signals through the sympathetic nervous system. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.